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Serum samples were obtained from healthcare work-
ers 5 weeks after exposure to an outbreak of severe acute
respiratory syndrome (SARS). A sensitive dot blot enzyme-
linked immunosorbent assay, complemented by a specific
neutralization test, shows that only persons in whom prob-
able SARS was diagnosed had specific antibodies and
suggests that subclinical SARS is not an important feature
of the disease. 
The Study
Severe acute respiratory syndrome (SARS) emerged
only in late 2002, but the rapid transmission of the disease
worldwide within a few months has led to serious public
health concerns. The putative agent of this new disease,
identified in March 2003, is a novel and more pathogenic
strain of the commonly occurring coronavirus (1,2). Cases
were initially defined according to syndrome features in
the absence of diagnostic tests (3). Knowledge of the epi-
demiology of SARS remains incomplete (4).
The proportion of persons infected with SARS-associ-
ated coronavirus (SARS-CoV) whose infection remained
subclinical is not known. Such information is important,
not only to facilitate understanding of the virulence of the
virus but, more importantly to determine whether the con-
trol measures currently employed are sufficient to halt the
spread of the virus. Should asymptomatic infection occur
in substantial numbers, the virus may continue to spread,
despite the isolation of the clinically apparent cases; how-
ever, this would result in the more rapid development of
herd immunity in the community. The aim of this study
was to determine the seroprevalence of anti–SARS-CoV
antibodies in a population of exposed healthcare workers
who worked in wards where an outbreak occurred.
At the beginning of April 2003, an outbreak of SARS
(diagnosed according to prevailing World Health
Organization guidelines) occurred in the surgical wards of
the Singapore General Hospital. The source was initially
unknown, and all staff and patients in these wards were
potentially exposed and were themselves potential sources
of the SARS virus. To contain the spread, healthcare work-
ers from these wards were either quarantined in their
homes for 2 weeks or sequestered with the patients and
continued to look after them, adopting full reverse-barrier
practices (5). 
Subsequent contact tracing pointed to an index case-
patient, whose infection led to 38 cases of SARS (in
healthcare workers, patients, and visitors) in these wards
and to another 12 cases of SARS in the rest of the hospital
campus before the outbreak was brought under control
3 weeks later. Of the 200 healthcare workers in the surgi-
cal wards quarantined or sequestered, SARS developed in
17, and milder symptoms developed in a number of others,
which did not qualify for a diagnosis of SARS under pre-
vailing WHO guidelines (3). 
The study was approved by the Ethics Committee of the
Singapore General Hospital. All 200 healthcare workers,
comprising doctors, nurses, health attendants, and recep-
tionists in these surgical wards who were quarantined after
the initial outbreak, were invited to participate. A total of
87 people volunteered. Of these, three had a history of
probable SARS but had recovered sufficiently to return to
work. Another group of 12 house officers, who joined the
department during the week the study started, were invited
to participate as negative controls because they had no
prior exposure to known SARS patients. Informed consent
was obtained from those who wished to take part.
Participants filled out a questionnaire about symptoms
experienced during the preceding weeks and donated a
sample of blood by venipuncture; the serum specimen was
stored at –80°C until use. Immunoglobulin (Ig) G antibod-
ies to SARS-CoV were detected by using a dot blot
enzyme-linked immunosorbent assay (ELISA) using a cul-
ture- derived, heat-inactivated virus antigen (E-E Ooi,
unpub. data) at a serum dilution of 1:100. When compared
to results of an indirect immunofluorescent assay in a lim-
ited study comprising 32 case-patients with clinically diag-
nosed SARS and 977 control serum samples collected
before the SARS outbreak, sensitivity and specificity were
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Singapore100% and 99.8%, respectively. Samples that tested posi-
tive for IgG antibodies to SARS-CoV were further assayed
for neutralizing antibodies by using the 50% tissue culture
infective dose (TCID50) method, similar to that previously
described (6), under biosafety level 3 conditions, in serial
twofold dilution, ranging from 1:10 to 1:320. The virus
isolate used in this study, SARS-CoV 2003VA2774, has
been previously sequenced (7) and was isolated from a
patient in whom SARS was diagnosed. All assays were
carried out in duplicate, and positive serum controls,
obtained from a volunteer convalescent-phase SARS
patient, were included in every run.
Four samples tested strongly positive by dot blot
ELISA, although only three of these were positive for neu-
tralizing antibodies with titers of 1:60, 1:60, and 1:320. All
three were volunteers in whom probable SARS was diag-
nosed. Nine other samples tested weakly positive by the
dot blot ELISA, although these samples were all negative
by neutralization test. Analysis of data provided by the
questionnaire showed that of the 84 exposed persons in
whom SARS did not develop, 32 had combinations of var-
ious symptoms. None of them had positive chest x-ray
findings.
Discussion
This is the first study to examine the seroprevalence of
anti–SARS-CoV antibodies in a population with a high
likelihood of having been exposed to the virus. The results
indicate that all samples positive for neutralizing antibod-
ies were from persons who had symptoms indicative of
SARS (Table). None of the healthcare workers studied
showed serologic evidence of subclinical infection. This
result strongly validates the current infection control meas-
ures to contain the spread of this virus, i.e., early identifi-
cation and isolation of case-patients. 
The finding of dot blot–positive, but neutralizing anti-
body–negative, specimens could be due to several factors.
We had chosen to screen the serum specimens at a low
dilution to increase their sensitivity, which would then be
confirmed by the serum neutralization test. False-positive
reactions to the screening test is thus expected.
Furthermore, these dot blot–positive specimens could be
due to cross-reaction with other coronaviruses (7).
Although negative findings in a small population are diffi-
cult to generalize, our results suggest that subclinical
infection is not an important feature of SARS. We are cur-
rently conducting larger population studies to further
investigate this finding.
In conclusion, in a population of healthcare workers
who worked in surgical wards at the time of the outbreak,
only those who sought treatment for probable SARS had
anti–SARS-CoV antibodies, suggesting no subclinical
infection. Early identification and isolation of cases are
thus effective infection control methods.
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Table. Symptoms of healthcare workers exposed to severe acute 
respiratory syndrome
a 
Symptoms  No. of persons 
Asymptomatic  52 
Systemic
b   28 
Upper respiratory tract
c   25 
Respiratory
d  15 
Gastrointestinal tract
e  10
 
Musculoskeletal
f  15 
aOf the 87 volunteers, 32 had symptoms that were not sufficient to qualify as 
having probable severe acute respiratory syndrome. None of the 32 had positive 
chest x-ray signs.  
bSystemic symptoms: fever, malaise, lethargy, headache. 
cUpper respiratory tract symptoms: runny nose, sore throat, sore mouth or gums. 
dRespiratory symptoms: cough, breathlessness, chest pain. 
eGastrointestinal tract symptoms: vomiting, diarrhea, abdominal colic. 
fMusculoskeletal symptoms: muscle ache, joint aches. 